Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma.
Suwanchiwasiri K, Phanthaphol N, Somboonpatarakun C, Yuti P, Sujjitjoon J, Luangwattananun P, Maher J, Yenchitsomanus PT, Junking M. Suwanchiwasiri K, et al. Among authors: phanthaphol n. Biomed Pharmacother. 2024 May 13;175:116718. doi: 10.1016/j.biopha.2024.116718. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38744221 Free article.
Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer.
Somboonpatarakun C, Phanthaphol N, Suwanchiwasiri K, Ramwarungkura B, Yuti P, Poungvarin N, Thuwajit P, Junking M, Yenchitsomanus PT. Somboonpatarakun C, et al. Among authors: phanthaphol n. Int Immunopharmacol. 2024 Mar 10;129:111631. doi: 10.1016/j.intimp.2024.111631. Epub 2024 Feb 14. Int Immunopharmacol. 2024. PMID: 38359664 Free article.
Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition.
Yuti P, Wutti-In Y, Sawasdee N, Kongkhla K, Phanthaphol N, Choomee K, Chieochansin T, Panya A, Junking M, Yenchitsomanus PT, Sujjitjoon J. Yuti P, et al. Among authors: phanthaphol n. Int Immunopharmacol. 2022 Dec;113(Pt B):109442. doi: 10.1016/j.intimp.2022.109442. Epub 2022 Nov 23. Int Immunopharmacol. 2022. PMID: 36435066 Free article.
Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells.
Wathikthinnakon M, Luangwattananun P, Sawasdee N, Chiawpanit C, Lee VS, Nimmanpipug P, Tragoolpua Y, Rotarayanont S, Sangsuwannukul T, Phanthaphol N, Wutti-In Y, Somboonpatarakun C, Chieochansin T, Junking M, Sujjitjoon J, Yenchitsomanus PT, Panya A. Wathikthinnakon M, et al. Among authors: phanthaphol n. Sci Rep. 2022 Apr 13;12(1):6154. doi: 10.1038/s41598-022-09964-6. Sci Rep. 2022. PMID: 35418130 Free PMC article.
11 results